Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer
IRF8; T cell exhaustion; antigen presentation; antigen-presenting cell; tumor-associated macrophage.- Immunity
- 26.3
- 2022 Nov 8;55(11):2044-2058.e5.
- Mouse
- 单细胞测序
- 免疫/内分泌
- Cells from Lymph Node
- 免疫/内分泌
- 巨噬细胞
- 肿瘤, 癌症, 巨噬细胞
- DOI: 10.1016/j.immuni.2022.10.002
Abstract
Tumors are populated by antigen-presenting cells (APCs) including macrophage subsets with distinct origins and functions. Here, we examined how cancer impacts mononuclear phagocytic APCs in a murine model of breast cancer. Tumors induced the expansion of monocyte-derived tumor-associated macrophages (TAMs) and the activation of type 1 dendritic cells (DC1s), both of which expressed and required the transcription factor interferon regulatory factor-8 (IRF8). Although DC1s mediated cytotoxic T lymphocyte (CTL) priming in tumor-draining lymph nodes, TAMs promoted CTL exhaustion in the tumor, and IRF8 was required for TAMs' ability to present cancer cell antigens. TAM-specific IRF8 deletion prevented exhaustion of cancer-cell-reactive CTLs and suppressed tumor growth. Tumors from patients with immune-infiltrated renal cell carcinoma had abundant TAMs that expressed IRF8 and were enriched for an IRF8 gene expression signature. Furthermore, the TAM-IRF8 signature co-segregated with CTL exhaustion signatures across multiple cancer types. Thus, CTL exhaustion is promoted by TAMs via IRF8. Keywords: IRF8; T cell exhaustion; antigen presentation; antigen-presenting cell; tumor-associated macrophage.
金课堂之文献解析 文献原文请点击
本网站销售的所有产品及服务均不得用于人类或动物之临床诊断或治疗,仅可用于工业或者科研等非医疗目的。



沪公网安备31011502400759号
营业执照(三证合一)